Toggle navigation
Home
Search
Services
Blog
Contact
About
Production and Testing of a Modified Vaccinia Ankara (MVA) Vaccine
Search grants from
Share this grant:
:
:
Abstract
Funding
Related projects
Comments
Recent in Grantomics:
Your institution
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
The Role of ZFP36 in Control of IPF
Complex Nanocomposites for Bone Regeneration
CD40 Signaling Through Tnf Receptor Associated Factors
Minority High School Student Research Apprentice Program
Acquisition of an Electron-beam Lithography System for Nanofabrication and Nanoscience Research and Education
Recently added grants:
Analysis of Big Data Squared in Biomedical Studies
Neuronal Circuit Mechanisms of Epileptogenesis
Cellular plasticity and equilibrium in GBM progression
Developmental Pathophysiology in Neocortex Caused By Somatic Mutations
The role of amyloid precursor protein in HIV-1 replication and associated neurodegeneration
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research and Development Contracts (N01)
Project #
N01AI40072-5-0-1
Application #
7580019
Study Section
Project Start
2004-09-30
Project End
2010-03-31
Budget Start
Budget End
Support Year
Fiscal Year
2007
Total Cost
Indirect Cost
Related projects
NIH 2008
N01 AI
Production and Testing of a Modified Vaccinia Ankara (MVA) Vaccine
/ Bavarian Nordic A/S
$4,850,824
NIH 2007
N01 AI
Chaplin, Paul /
NIH 2007
N01 AI
Production and Testing of a Modified Vaccinia Ankara (MVA) Vaccine
/
Comments
Be the first to comment on this grant